Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine

NCT00825058 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

317

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorders

Interventions

DRUG: amibegron (SR58611A)
DRUG: placebo
DRUG: paroxetine

Sponsor

Sanofi